Wang, Y.

cancer endometrial progesterone surplus accounting wnt /β-catenin expression income surplus flows disease /β-catenin endometrial cancer dkk 1 pathway patient surplus accounting flows value receptor tumor endometrium catenin regulation progesterone receptor treatment return inhibition presence value relevance carcinoma analysis foxo 1 interval table staining model sample surplus items 1 nm mpa number journal result ishikawa factor netherland cycle β- catenin level study relevance information asset revaluations stock returns surplus income wnt /b earning period goodwill write-offs accounting information non-progressive dutch group ikprab equity university currency-translation differences phase women endometrial carcinoma statement revaluation stock market cd 44 staining hyperplasia ishikawa cells issue -36 asset 387–405 activation